Gencurix Inc. (KOSDAQ:229000)
1,536.00
+26.00 (1.72%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cancer Diagnosis (Prognostic Diagnosis + Companion Diagnosis) | 4.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cancer Diagnosis (Prognostic Diagnosis + Companion Diagnosis) Growth | 92.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 510.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 159.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Genetic Analysis | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Genetic Analysis Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rental | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rental Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| South Korea | 4.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 88.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 433.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 297.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|